Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 19, 2018 - The FDA announced the approval of IBSA Pharma’s Licart (diclofenac epolamine), for the topical treatment of acute pain due to minor strains, sprains, and contusions.
Download PDF
Return to publications
